Bayer HealthCare articles over last 30 days

- articles last 30 days - articles per day
Mentioned in this news Places Companies People
2014/08/28 15:29
2014/08/28 15:29
20h
Bayer HealthCare appears to be the first pharmaceutical company to have started its own accelerator. The company that made €18.924 million in turnover in 2013 “understands that innovation and...
2014/08/28 15:29
2014/08/28 15:29
Latest videos
2014/08/27 12:17
2014/08/27 12:17
1d
BEIJING--(BUSINESS WIRE)--BeiGene (Beijing), Co., Ltd., an innovative oncology company focused on developing targeted and immune-oncology therapeutics, today announced the additions of two senior...
2014/08/25 03:21
2014/08/25 03:21
4d
Daniel Welch is chairman, president and CEO of InterMune Inc. The $74-per-share, all-cash deal really is no surprise. Rumors of a buyout by any one of a handful of Big Pharma players surged as...
2014/08/21 08:00
2014/08/21 08:00
8d
Editor, My three sisters and a good friend have decided to lower their cancer risk and strengthen their marriages by not ingesting birth control pills. They learned that the pill...
2014/08/18 16:28
2014/08/18 16:28
10d
Condoms are being rejected in favour of sandwich bags and cling film, claims German survey(Getty) Safe sex messages are failing to hit home, judging by research which shows lovers in Britain are...
Bayer
MENTIONED
2014/08/18 14:22
2014/08/18 14:22
10d
The survey found a quarter of British women had heard of people using such DIY methods. But it wasn't the only shocking result turned up by German company Bayer HealthCare, who asked 1,500 British...
Read more at Daily Mirror, metro
2014/08/15 10:17
2014/08/15 10:17
14d
SOMERSET, New Jersey--(BUSINESS WIRE)--Catalent, Inc. (NYSE :CTLT), le leader mondial en solutions de développement de médicaments et technologies d’administration de médicaments avancées pour les...
2014/08/15 10:17
2014/08/15 10:17
14d
SOMERSET, NEW JERSEY, USA--(BUSINESS WIRE)--Catalent, Inc. (NYSE:CTLT), der weltweit führende Anbieter von hochmodernen Wirkstoffabgabetechnologien und Entwicklungslösungen für Arzneimittel, Biologika...
2014/08/15 03:17
2014/08/15 03:17
14d
SOMERSET, N.J.--(BUSINESS WIRE)--A Catalent, Inc. (NYSE:CTLT), líder global em soluções para desenvolvimento de fármacos e tecnologias de aplicação avançadas para produtos farmacêuticos, biológicos e...
2014/08/15 03:15
2014/08/15 03:15
14d
BRONX, NEW YORK (PIX11) — Lisa Saenz, 45, slid with great discomfort into a living room recliner, four days after she underwent a hysterectomy. The mother of three daughters didn’t have the operation...
2014/08/15 01:17
2014/08/15 01:17
14d
SOMERSET, N.J.--(BUSINESS WIRE)--Catalent, Inc. (NYSE:CTLT), the global leader in drug development solutions and advanced delivery technologies for pharmaceutical, biologic, and consumer health...
2014/08/13 18:33
2014/08/13 18:33
15d
Comedian Joel McHale juggles a lot of different hats. He hosts "The Soup" on E! Network, stars on the TV hit "Community," acts in movies and is also the father of 2 young boys. "I have multiple jobs...
2014/08/12 19:17
2014/08/12 19:17
16d
NEW YORK--(BUSINESS WIRE)--The National Hemophilia Foundation (NHF) and Impact Education, LLC (IE) are pleased to announce the second annual pre-conference symposium specifically designed for...
2014/08/11 08:08
2014/08/11 08:08
18d
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that EYLEA® (aflibercept) Injection has been approved by the European Commission for the treatment of visual impairment due to Diabetic...
2014/08/05 14:41
2014/08/05 14:41
23d
The European Commission has granted approval to Bayer HealthCare’s oncology drug Stivarga (regorafenib) for the treatment of patients with unresectable or metastatic gastrointestinal stromal tumors...
2014/08/04 19:17
2014/08/04 19:17
24d
... Annual Canaccord Genuity Growth Conference3:30pm ET, August 13, Boston, MA The Company is also participating in the UBS 2014 Biotech Summer 1x1 Conference August 7, 2014 in Boston, MA. About...
2014/07/30 10:08
2014/07/30 10:08
30d
In an era of austerity, governments are focusing on value. Value is being defined by primary and secondary health outcomes for citizens, and medicines are just part of the treatment. This is forcing...
2014/07/28 07:53
2014/07/28 07:53
m
If you are interested in this story, you might be interested in others from The Journal Gazette. Go to www.journalgazette.net/newsletter and pick the subjects you care most about. We'll deliver your...
2014/07/25 09:08
2014/07/25 09:08
m
Bayer HealthCare and Onyx Pharmaceuticals Inc., an Amgen subsidiary (NASDAQ: AMGN), today announced that an investigational Phase 3 trial of NEXAVAR® (sorafenib) tablets in patients with advanced...
2014/08/28 15:29
2014/08/28 15:29
Latest from Twitter